FDA Import Refusal 1FX-1301431-1/20002/4 — Intas Pharmaceuticals Limited
The FDA refused shipment 1FX-1301431-1/20002/4 from Intas Pharmaceuticals Limited (India) on Aug 3, 2026. The refused product falls under Drugs and Biologics — CHLORZOXAZONE (RELAXANT). Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Aug 3, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 65QBA31 CHLORZOXAZONE (RELAXANT)
- Charges
- 118,75